financetom
Business
financetom
/
Business
/
Super Micro Computer Plans Common Stock Offering; Shares Slump
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Super Micro Computer Plans Common Stock Offering; Shares Slump
Mar 19, 2024 12:59 PM

03:32 PM EDT, 03/19/2024 (MT Newswires) -- Super Micro Computer ( SMCI ) said Tuesday it plans to sell 2 million common shares in a public offering, sending the artificial intelligence server maker's stock tumbling.

The company expects to grant a 30-day overallotment option to underwriter Goldman Sachs to acquire up to 300,000 additional shares in the offering, which is subject to market and other conditions, it said.

Super Micro shares were sliding 11% in Tuesday late afternoon trade.

"The principal purposes of this offering are to obtain additional capital to support our operations, including for the purchase of inventory and other working capital purposes, manufacturing capacity expansions and increased research and development investments," the company said in a filing with the US Securities and Exchange Commission.

The shares closed at $1,000.68 Monday. So far this year, the company's shares are up more than 200%. Super Micro joined the S&P 500 index Monday.

In January, Super Micro reported that its fiscal second-quarter adjusted earnings rose to $5.59 a share from $3.26 a year earlier, while revenue jumped 103% to $3.66 billion, with both metrics topping Wall Street estimates.

The company said at the time that it expected third-quarter revenue in a range of $3.7 billion to $4.1 billion and full-year revenue between $14.3 billion and $14.7 billion. The Street is looking for $3.9 billion and $14.59 billion, respectively.

"We expect a strong March quarter as we continue to gain momentum with new and existing customers for our AI and rack-scale total IT solutions," Chief Financial Officer David Weigand said on an earnings conference call in January, according to a Capital IQ transcript.

"Next-generation AI and CPU platforms continue to drive strong levels of design wins," Weigand said.

Price: 893.66, Change: -107.02, Percent Change: -10.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved